Innovative Approaches to Advancing Promising Preclinical Compounds
Investment Type: Venture Capital
Mentions in press and media 2
| Date | Title | Description |
| 26.03.2014 | CROs as early-stage life science investors? ‘It’s the model of the future,’ one says | Contract research organizations make good money providing critical services to young biotech and drug development companies early on. But often, those companies are cash-strapped at the stage when they need a CRO. That’s why some CROs are b... |
| - | CROs as early-stage life science investors? ‘It’s the model of the future,’ one says | Contract research organizations make good money providing critical services to young biotech and drug development companies early on. But often, those companies are cash-strapped at the stage when they need a CRO. That’s why some CROs are b... |